Cisco Sys (CSCO) Holder Covenant Multifamily Offices Decreased Holding by $4.33 Million; As Gilead Sciences (GILD) Valuation Declined, Holder Clearbridge Investments Has Boosted Its Holding

August 12, 2018 - By Victoria Pittman

Gilead Sciences, Inc. (NASDAQ:GILD) Logo

Covenant Multifamily Offices Llc decreased its stake in Cisco Sys Inc (CSCO) by 92.62% based on its latest 2018Q1 regulatory filing with the SEC. Covenant Multifamily Offices Llc sold 103,090 shares as the company’s stock declined 4.63% with the market. The institutional investor held 8,217 shares of the technology company at the end of 2018Q1, valued at $352,000, down from 111,307 at the end of the previous reported quarter. Covenant Multifamily Offices Llc who had been investing in Cisco Sys Inc for a number of months, seems to be less bullish one the $210.72 billion market cap company. The stock decreased 1.15% or $0.51 during the last trading session, reaching $43.74. About 19.03M shares traded. Cisco Systems, Inc. (NASDAQ:CSCO) has risen 37.60% since August 12, 2017 and is uptrending. It has outperformed by 25.03% the S&P500. Some Historical CSCO News: 16/05/2018 – Cisco Systems 3Q Non-GAAP Total Gross Margin and Pdt Gross Margin Were 63.9% and 62.9%, Respectively; 28/03/2018 – CISCO – MARIA MARTINEZ WILL SERVE AS COMPANY’S EXECUTIVE VICE PRESIDENT AND CHIEF CUSTOMER EXPERIENCE OFFICER; 16/05/2018 – CISCO 3Q REV. $12.5B, EST. $12.44B; 28/03/2018 – ARISTA NETWORKS INC – ALJ SUPPORTED SUSPENSION OF REMEDIES CONCERNING ‘668 PATENT PENDING COMPLETION OF CISCO’S APPEALS OF DECISION; 16/05/2018 – Cisco drops despite earnings beat; 16/05/2018 – Cisco Systems Declared and Paid Cash Div of 33c/Share, or $1.6 Billion, in 3Q; 23/05/2018 – Cisco’s Talos Unit Warns Of Possible Cyberattack On Ukraine — MarketWatch; 07/03/2018 – Tech Data Adds Cisco Spark and Cisco Umbrella Cloud Solutions to StreamOne Cloud Marketplace; 16/04/2018 – Gong.io Extends A1 Funding Round With Investment From Cisco Investments; 05/03/2018 Teradata Unlocks IoT Value for Smart Cities with Cisco Integration

Clearbridge Investments Llc increased its stake in Gilead Sciences Inc (GILD) by 474.57% based on its latest 2018Q1 regulatory filing with the SEC. Clearbridge Investments Llc bought 64,124 shares as the company’s stock declined 17.62% with the market. The institutional investor held 77,636 shares of the health care company at the end of 2018Q1, valued at $5.85M, up from 13,512 at the end of the previous reported quarter. Clearbridge Investments Llc who had been investing in Gilead Sciences Inc for a number of months, seems to be bullish on the $99.47B market cap company. The stock decreased 1.68% or $1.31 during the last trading session, reaching $76.73. About 4.83M shares traded. Gilead Sciences, Inc. (NASDAQ:GILD) has risen 4.37% since August 12, 2017 and is uptrending. It has underperformed by 8.20% the S&P500. Some Historical GILD News: 05/03/2018 – GILEAD: BIKTARVY FOUND TO BE NON-INFERIOR TO ABACAVIR REGIMEN; 05/03/2018 – GSK: ViiV Interim Results Show Dolutegravir Effective, Well-Tolerated in HIV/TB Patients; 05/03/2018 – GLAXOSMITHKLINE PLC – DOLUTEGRAVIR WAS WELL-TOLERATED IN HIV/TB CO-INFECTED ADULTS RECEIVING RIFAMPIN-BASED TB THERAPY; 15/05/2018 – Gilead’s Kite Leases New Facility in Netherlands to Engineer Cell Therapies in Europe; 18/05/2018 – U.S. FDA SAYS ALERTING PUBLIC TO SERIOUS CASES OF NEURAL TUBE BIRTH DEFECTS REPORTED IN BABIES BORN TO WOMEN TREATED WITH DOLUTEGRAVIR USED TO TREAT HIV; 16/04/2018 – GILD: NEW: SCOTUS asks the solicitor general to weigh in on a False Claims Act petition (Gilead Sciences Inc. v. U.S. es rel. Campie, No. 17-936). The materiality issue raised in that case could affect a related retaliation claim brought by the employee; 21/05/2018 – JULUCA Dolutegravir/rilpivirine Combines Two Antiretrovirals in a Single-Pill Regimen; 05/04/2018 – U.S. Medicare sets outpatient rate for Yescarta reimbursement; 18/05/2018 – FDA- PRELIM RESULTS FROM ONGOING STUDY FOUND WOMEN GETTING DOLUTEGRAVIR AT TIME OF BECOMING PREGNANT/EARLY IN FIRST TRIMESTER APPEAR AT HIGHER RISK FOR DEFECTS; 16/04/2018 – Gilead’s Harvoni Falls For 2nd Wk, Epclusa Declines: Hep-C

More notable recent Cisco Systems, Inc. (NASDAQ:CSCO) news were published by: Nasdaq.com which released: “7 Tech Stocks That Pay Dividends” on August 07, 2018, also Seekingalpha.com with their article: “Cisco: Buyback By The Numbers” published on July 25, 2018, Seekingalpha.com published: “Cisco Acquisition Of Duo Security Makes Sense” on August 03, 2018. More interesting news about Cisco Systems, Inc. (NASDAQ:CSCO) were released by: Nasdaq.com and their article: “Amazon Isn’t Coming After Cisco, After All” published on July 20, 2018 as well as Seekingalpha.com‘s news article titled: “Stocks To Watch: Any Privacy For Tesla?” with publication date: August 11, 2018.

Analysts await Cisco Systems, Inc. (NASDAQ:CSCO) to report earnings on August, 15 after the close. They expect $0.63 EPS, up 14.55% or $0.08 from last year’s $0.55 per share. CSCO’s profit will be $3.04 billion for 17.36 P/E if the $0.63 EPS becomes a reality. After $0.60 actual EPS reported by Cisco Systems, Inc. for the previous quarter, Wall Street now forecasts 5.00% EPS growth.

Investors sentiment decreased to 0.73 in 2018 Q1. Its down 0.30, from 1.03 in 2017Q4. It dived, as 66 investors sold CSCO shares while 798 reduced holdings. 170 funds opened positions while 464 raised stakes. 3.40 billion shares or 4.18% less from 3.54 billion shares in 2017Q4 were reported. Private Ocean Ltd Liability Corporation reported 5,247 shares. M Kraus & holds 4.07% or 149,297 shares in its portfolio. Affinity Advsr Ltd Company stated it has 2.15% of its portfolio in Cisco Systems, Inc. (NASDAQ:CSCO). Avalon Global Asset Mgmt invested in 95,000 shares or 1.41% of the stock. Bluemountain Cap Mgmt Limited Com has 0.2% invested in Cisco Systems, Inc. (NASDAQ:CSCO) for 202,061 shares. Huntington National Bank reported 1.41M shares. Schwartz Inv Counsel owns 865,000 shares or 2.19% of their US portfolio. Lincluden Mgmt reported 400,191 shares. Suffolk Capital Management Ltd owns 80,154 shares or 0.49% of their US portfolio. Blair William & Communication Il stated it has 0.37% of its portfolio in Cisco Systems, Inc. (NASDAQ:CSCO). Columbia Prns L L C Inv reported 200,571 shares. Covington Inv Advsrs holds 1.71% of its portfolio in Cisco Systems, Inc. (NASDAQ:CSCO) for 124,294 shares. Bernzott Capital Advsrs accumulated 2% or 359,053 shares. 87,491 were reported by Aimz Invest Advsr Ltd Com. Nikko Asset Mngmt Americas owns 62,384 shares for 0.1% of their portfolio.

Since February 20, 2018, it had 0 buys, and 4 sales for $3.63 million activity. SARIN ARUN sold $625,751 worth of stock. Shares for $550,153 were sold by BURNS M MICHELE.

Covenant Multifamily Offices Llc, which manages about $1.34B and $166.60M US Long portfolio, upped its stake in Ishares Tr S&P 100 Index Fund (OEF) by 6,270 shares to 35,032 shares, valued at $4.06M in 2018Q1, according to the filing. It also increased its holding in At&T Inc Com (NYSE:T) by 13,115 shares in the quarter, for a total of 19,154 shares, and has risen its stake in Paychex Inc Com (NASDAQ:PAYX).

Among 39 analysts covering Cisco Systems Inc. (NASDAQ:CSCO), 29 have Buy rating, 0 Sell and 10 Hold. Therefore 74% are positive. Cisco Systems Inc. had 174 analyst reports since August 4, 2015 according to SRatingsIntel. RBC Capital Markets maintained the shares of CSCO in report on Monday, July 31 with “Buy” rating. The firm earned “Buy” rating on Monday, October 9 by RBC Capital Markets. The stock has “Hold” rating by BMO Capital Markets on Wednesday, June 28. The firm has “Underperform” rating by Macquarie Research given on Tuesday, August 4. The stock has “Buy” rating by Oppenheimer on Wednesday, August 16. The company was maintained on Thursday, August 18 by KeyBanc Capital Markets. As per Friday, September 23, the company rating was maintained by Raymond James. The stock has “Buy” rating by Goldman Sachs on Friday, March 23. The firm has “Neutral” rating by Bank of America given on Tuesday, April 5. As per Thursday, November 16, the company rating was maintained by Citigroup.

Clearbridge Investments Llc, which manages about $105.97 billion US Long portfolio, decreased its stake in Berkshire Hathaway Inc Del (BRKB) by 20,882 shares to 2.29 million shares, valued at $455.83 million in 2018Q1, according to the filing. It also reduced its holding in Autodesk Inc (NASDAQ:ADSK) by 388,615 shares in the quarter, leaving it with 9.88 million shares, and cut its stake in Simon Ppty Group Inc New (NYSE:SPG).

Since February 9, 2018, it had 0 insider purchases, and 17 selling transactions for $25.62 million activity. Washington Robin L sold 5,000 shares worth $401,566. Shares for $3.66 million were sold by MARTIN JOHN C. 25,000 Gilead Sciences, Inc. (NASDAQ:GILD) shares with value of $1.97 million were sold by Alton Gregg H. WILSON GAYLE E sold 60,000 shares worth $4.68M.

More notable recent Gilead Sciences, Inc. (NASDAQ:GILD) news were published by: Nasdaq.com which released: “Will Strong HIV Sales Fuel Gilead (GILD) In Q2 Earnings?” on July 23, 2018, also Seekingalpha.com with their article: “Gilead’s Stock Price Is Ready To Soar” published on July 30, 2018, Seekingalpha.com published: “Gilead Sciences: Stabilisation In Sight” on July 27, 2018. More interesting news about Gilead Sciences, Inc. (NASDAQ:GILD) were released by: Nasdaq.com and their article: “Gilead Sciences (GILD) Q2 Earnings and Revenues Surpass Estimates” published on July 25, 2018 as well as 247Wallst.com‘s news article titled: “Why Have Short Sellers Backed Off Major Biotechs?” with publication date: August 10, 2018.

Among 32 analysts covering Gilead Sciences (NASDAQ:GILD), 22 have Buy rating, 0 Sell and 10 Hold. Therefore 69% are positive. Gilead Sciences had 135 analyst reports since July 29, 2015 according to SRatingsIntel. Barclays Capital maintained Gilead Sciences, Inc. (NASDAQ:GILD) on Wednesday, May 2 with “Overweight” rating. Wells Fargo maintained Gilead Sciences, Inc. (NASDAQ:GILD) on Friday, December 4 with “Market Perform” rating. The stock has “Overweight” rating by PiperJaffray on Thursday, May 31. On Monday, August 17 the stock rating was upgraded by Vetr to “Buy”. The firm has “Overweight” rating by Piper Jaffray given on Friday, July 24. The firm has “Buy” rating by Standpoint Research given on Wednesday, February 3. The company was maintained on Wednesday, February 3 by Piper Jaffray. The stock of Gilead Sciences, Inc. (NASDAQ:GILD) has “Buy” rating given on Friday, April 29 by UBS. The rating was maintained by Credit Suisse on Wednesday, February 3 with “Outperform”. The rating was maintained by Oppenheimer on Wednesday, July 29 with “Outperform”.

Investors sentiment increased to 0.88 in 2018 Q1. Its up 0.08, from 0.8 in 2017Q4. It increased, as 71 investors sold GILD shares while 519 reduced holdings. 114 funds opened positions while 404 raised stakes. 976.44 million shares or 0.39% more from 972.68 million shares in 2017Q4 were reported. Hsbc Public Limited Liability holds 0.35% or 3.11 million shares in its portfolio. Montag A Associates stated it has 39,886 shares or 0.31% of all its holdings. Sand Hill Glob Advisors Ltd Llc has 6,397 shares. Alpha Cubed Limited Liability has invested 0.27% in Gilead Sciences, Inc. (NASDAQ:GILD). Hartford Fin Management invested in 0.01% or 140 shares. Cap Advsr Llc stated it has 0.02% in Gilead Sciences, Inc. (NASDAQ:GILD). Peak Asset Management Limited Liability Com owns 80,598 shares or 2.23% of their US portfolio. Mariner Ltd Company accumulated 76,573 shares or 0.21% of the stock. Oarsman Capital owns 32,624 shares for 1.12% of their portfolio. Laurion Management Lp has invested 0.01% in Gilead Sciences, Inc. (NASDAQ:GILD). Aperio Group invested 0.37% of its portfolio in Gilead Sciences, Inc. (NASDAQ:GILD). Dorsey Whitney Commerce Ltd Liability Corporation has invested 0.11% in Gilead Sciences, Inc. (NASDAQ:GILD). Northside Cap Management Ltd Liability Company holds 0.17% or 6,787 shares in its portfolio. Chilton Mngmt Ltd Limited Liability Company reported 16,610 shares. Old Mutual Global Invsts (Uk) Ltd has invested 0.03% in Gilead Sciences, Inc. (NASDAQ:GILD).

Gilead Sciences, Inc. (NASDAQ:GILD) Institutional Positions Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter:


Recent Posts